Imagen de Portada

Routine screening for HLA Antibodies in Heart Transplant patients—Does it affect clinical decision making?

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Tor Skibsted Clemmensen, Johanne Hjort Baatrup, Kamilla Pernille Bjerre, Emil Lichscheidt, Pernille Koefoed Nielsen, Hans Eiskjaer
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association of HLA B‐ and T‐cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation
por: Ann‐Maria Gramkow, et al.
Publicado: (2024)

The Impact of Reduced Immunosuppression on Alloimmunity: A Retrospective Study of Pediatric Kidney Transplant Recipients
por: Ann‐Maria Gramkow, et al.
Publicado: (2024)

Daratumumab for Anti‐ HLA Antibody Desensitization and Antibody Mediated Rejection in Pediatric Heart Transplant Patients
por: Caitlin Milligan, et al.
Publicado: (2025)

Impact of Anti‐ HLA Antibody Desensitization Strategies in Pediatric Heart Transplant Recipients: A PHTS ‐ PHIS Linkage Analysis
por: Deipanjan Nandi, et al.
Publicado: (2026)

Characterisation of the Novel HLA‐A*01:501 and HLA‐C*05:316 Alleles Identified in Danish Individuals
por: Maja Nørgaard, et al.
Publicado: (2026)

The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
por: Qingyong Xu, et al.
Publicado: (2026)

Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)

Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
por: Meagan O. Rogers, et al.
Publicado: (2024)

Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation
por: Dana Dlouha, et al.
Publicado: (2025)

Impact of the Distance Between Patient Residency and Heart Transplant Center on Outcomes After Heart Transplantation
por: Waleed Ahmad, et al.
Publicado: (2024)

Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation
por: Yeahwa Hong, et al.
Publicado: (2025)

Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
por: Orly Leiva, et al.
Publicado: (2025)

Pre‐Transplant Immunophenotyping in Pediatric Heart Transplant: A Role for the Immunologist?
por: Lauren Gunderman, et al.
Publicado: (2025)

Donor‐Derived Cell‐Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series
por: Anusha Konduri, et al.
Publicado: (2025)

Associated Factors to Nonadherence to Routine Appointments after Kidney Transplantation: The ADHERE Brazil Study
por: Roberta Lopes Karlburger, et al.
Publicado: (2025)

Sex‐Based Disparities in Heart Transplantation in Teenagers
por: Mohan M. John, et al.
Publicado: (2025)

The Nordic Experience of Pediatric Heart‐Lung Transplantation
por: Oscar van der Have, et al.
Publicado: (2026)

Antibodies as Therapy: A Coming of Age in Transplantation
por: Andrew Karaba, et al.
Publicado: (2026)

Impact of Age of Heart Transplant Program on Patient Survival and Post‐Transplant Outcomes
por: David T. Majure, et al.
Publicado: (2024)

Higher Hospitalization Costs and Fewer Routine Discharges in the Medicaid Expansion Era for Lung Transplant Recipients
por: Andrew Kalra, et al.
Publicado: (2024)

Aggressive Management of a Bilateral Chylothorax Complicating an Orthotopic Heart-Kidney Transplantation
por: Breah Lynn Paciotti
Publicado: (2023)

Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
por: Armaan F. Akbar, et al.
Publicado: (2024)

Donation After Circulatory Death in Pediatric Heart Transplantation
por: Sarah Dudley Grorud, et al.
Publicado: (2026)

Impact of Pharmacogenomic Testing in Pediatric Heart and Kidney Transplant
por: Rachel L. Jackson, et al.
Publicado: (2025)

Impact of Pre‐Heart Transplant Levosimendan Administration on Post‐Transplant Vasoplegia and Primary Graft Dysfunction
por: Joan Guzman‐Bofarull, et al.
Publicado: (2025)

Importance of Transplant Era on Post–Heart Transplant Predictive Models: A UNOS Cohort Analysis
por: Mickaël Lescroart, et al.
Publicado: (2024)

Incidence and Management of Posttransplantation Lymphoproliferative Disorder After Pediatric Solid Organ Transplantation: The Norwegian Experience
por: Olav Sondre Skorge Aartun, et al.
Publicado: (2025)

Clinical Characteristics and Outcomes Associated With Immediate Versus Delayed Presentation of Severe Primary Graft Dysfunction After Heart Transplantation: Does Timing Matter?
por: Yosef Manla, et al.
Publicado: (2025)

Combined Heart and Kidney Transplantation: Initial Clinical Experience
por: Fernando Antibas Atik
Publicado: (2022)

Donor Characteristics and Outcomes of Pediatric Heart Transplantation in South Korea
por: Susan Taejung Kim, et al.
Publicado: (2024)

Machine Learning for Predicting Waitlist Mortality in Pediatric Heart Transplantation
por: Firezer Haregu, et al.
Publicado: (2025)

Screening and Surveillance for Colorectal Cancer Before and After Heart Transplantation
por: Madeline E. Abrams, et al.
Publicado: (2025)

Rethinking Desensitization in Pediatric Heart Transplantation: Moving Beyond PRA
por: Lakshmi R. Gokanapudy Hahn, et al.
Publicado: (2026)

Kidney Transplantation in Congenital Heart Disease Patients: What Are the Outcomes?
por: Mario O'Connor, et al.
Publicado: (2025)

Alternative Measures of Body Composition and Outcomes Following Heart Transplant
por: Ana Lanier, et al.
Publicado: (2026)

Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
por: Lien‐Chung Wei, et al.
Publicado: (2025)

Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation
por: Manuj M. Shah, et al.
Publicado: (2024)

Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
por: Cathrine M. Moeller, et al.
Publicado: (2024)

Sex Differences in Incidence and Outcomes of New‐Onset Post‐Transplant Diabetes Mellitus After Heart Transplantation
por: Alice Chung, et al.
Publicado: (2025)

Tocilizumab as Adjuvant Therapy in Refractory Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients
por: Anne M. Durkan, et al.
Publicado: (2025)